Rafa Laboratories secured a BARDA contract to develop an intramuscular TXA injection for prehospital bleeding care.
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback